HopeStage
Back to all studies
Not Yet RecruitingNCT06854029

Long-acting versus daily medicines for HIV prevention and opioid use in prisons

About this title

NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings

Read the official source — NCT06854029
Medication studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
DurhamSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: September 1, 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
450
Sponsor
Duke University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT06854029
Official title
Show the full official title

Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings

Recruitment & locations

Not yet recruiting

Durham

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Duke University, a university.

Does this study involve medication?

Yes. The study involves medication, including Cabotegravir Injection, Cabotegravir Pill, Buprenorphine injection and Buprenorphine Pill.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies